1.Gunal N., Baysal K., Haciomeroglu P. et al. Rheumatic heart disease and coronary vasculitis in children. Acta Paediatr. 2006; 95(1): 118-20.2.Kim S.S., Lim S.H., Hong Y.S. et all. Tissue engineering of heart valves in vivo using bone marrow-derived cells. Artif. Organs 2006; 30(7): 554-7.3.Knight R.L., Booth C., Wilcox H.E. et al. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells. J. Heart. Valve Dis. 2005; 14(6): 806-13.4.Rieder E., Seebacher G., Kasimir M.-T. et al. Tissue engineering of heart valves decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells valve. Circulation 2005; 111(21): 2792-7.5.Takagi K., Fukunaga S., Nishi A. et al. In vivo recellularization of plain decellularized xenografts with specific cell characterization in the systemic circulation: histological and immunohistochemical study. Artif. Organs 2006; 30(4): 233-41.6.Visconti R., Mironov V., Kasyanov V.A. et al. Cardiovascular tissue engineering I. Perfusion bioreactors: a review. J. Long Term. Eff. Med. Implants 2006; 16(2): 111-30.7.Åbotari S., Mertsching H., Kallenbach K. et al. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 2002; 106: 163-8.